SCHEMBL9554563

SCHEMBL9554563

N[C@@H](CN[C@@H](Cc1cnc[nH]1)C(=O)O)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GGT1 P19440 2/20 0.55
▸ REN P00797 1/20 0.55
▸ CYP3A4 P08684 2/20 0.52
▸ SLC7A5 Q01650 1/20 0.52
▸ AGTR2 P50052 1/20 0.52
▸ ITGB2 P05107 2/20 0.51
▸ ICAM1 P05362 2/20 0.51
▸ ITGAL P20701 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ CA1 P00915 2/20 0.48
▸ CA2 P00918 2/20 0.48
▸ CPA1 P15085 1/20 0.48
▸ LTA4H P09960 1/20 0.47
▸ MME P08473 1/20 0.47
▸ ECE1 P42892 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16673595 0.84 AGTR2 (0.58) RENCYP3A4SLC7A5AGTR2ITGB2
SCHEMBL3599440 0.84 AGTR2 (0.57) GGT1RENCYP3A4SLC7A5AGTR2
SCHEMBL5907039 0.84 AGTR2 (0.57) GGT1RENCYP3A4SLC7A5AGTR2
SCHEMBL28133942 0.83 REN (0.60) RENCYP3A4SLC7A5AGTR2ITGB2
SCHEMBL29971719 0.83 REN (0.60) RENCYP3A4SLC7A5AGTR2ITGB2
SCHEMBL8250332 0.82 AGTR2 (0.61) RENCYP3A4SLC7A5AGTR2ITGB2
SCHEMBL5869520 0.82 AGTR2 (0.61) RENCYP3A4SLC7A5AGTR2ITGB2
SCHEMBL1667212 0.81 ALDH1A1 (0.54) CYP3A4ITGB2ICAM1ITGALALDH1A1
SCHEMBL30184773 0.81 AGTR2 (0.60) RENCYP3A4SLC7A5AGTR2ITGB2
SCHEMBL27826956 0.81 AGTR2 (0.60) RENCYP3A4SLC7A5AGTR2ITGB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250517-A Hypotensive and cardiotonic agents; cardiac insufficiency HOFFMANN-LA ROCHE INC. (US) 1993-10-05 — — US disclosed
Send feedback